Evidence map›Paper›PMID 28515678›Full record

ArticleFrontiers in molecular neuroscience2017

Soluble Ectodomain of Neuroligin 1 Decreases Synaptic Activity by Activating Metabotropic Glutamate Receptor 2.

Michelle D Gjørlund, Eva M M Carlsen, Andreas B Kønig, Oksana Dmytrieva, Anders V Petersen, Jacob Jacobsen, Vladimir Berezin, Jean-François Perrier, Sylwia Owczarek

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michelle D GjørlundLaboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
Eva M M CarlsenNeuronal Signaling Laboratory, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
Andreas B KønigLaboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
Oksana DmytrievaLaboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
Anders V PetersenNeuronal Signaling Laboratory, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
Jacob JacobsenDepartment of Biology, University of CopenhagenHelsingør, Denmark.
Vladimir BerezinNeuronal Signaling Laboratory, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
Jean-François PerrierNeuronal Signaling Laboratory, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
Sylwia OwczarekLaboratory of Neural Plasticity, Department of Neuroscience and Pharmacology, University of CopenhagenCopenhagen, Denmark.
University of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synaptic cell adhesion molecules represent important targets for neuronal activity-dependent proteolysis. Postsynaptic neuroligins (NLs) form trans-synaptic complexes with presynaptic neurexins (NXs). Both NXs and NLs are cleaved from the cell surface by metalloproteases in an activity-dependent manner, releasing a soluble extracellular fragment and membrane-tethered C-terminal fragment. The cleavage of NL1 depresses synaptic transmission, but the mechanism by which this occurs is unknown. Metabotropic glutamate receptor 2 (mGluR2) are located primarily at the periphery of presynaptic terminals, where they inhibit the formation of cyclic adenosine monophosphate (cAMP) and consequently suppress the release of glutamate and decrease synaptic transmission. In the present study, we found that the soluble ectodomain of NL1 binds to and activates mGluR2 in both neurons and heterologous cells, resulting in a decrease in cAMP formation. In a slice preparation from the hippocampus of mice, NL1 inhibited the release of glutamate from mossy fibers that project to CA3 pyramidal neurons. The presynaptic effect of NL1 was abolished in the presence of a selective antagonist for mGluR2. Thus, our data suggest that the soluble extracellular domain of NL1 functionally interacts with mGluR2 and thereby decreases synaptic strength.

Indexed as

cell adhesion moleculehippocampusproteolytic cleavagesynaptic activity

Identifiers

PMID28515678
PMCPMC5413576
OpenAlexW2611859209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.